Orientação de alta e acompanhamento telefônico na adesão terapêutica da insuficiência cardíaca: ensaio clínico randomizado

• Main Author: Oscalices, Monica Isabelle Lopes
• Publication Date: 2019
• Other Authors: Okuno, Meiry Fernanda Pinto, Lopes, Maria Carolina Barbosa Teixeira, Campanharo, Cassia Regina Vancini, Batista, Ruth Ester Assayag
• Format: Article
• Language: spa; eng; por
• Source: Revista Latino-Americana de Enfermagem (Online)
• Download full: https://www.revistas.usp.br/rlae/article/view/183431
• topic: Heart Failure; Education; Clinical Trial; Nursing; Emergency Nursing; Patient’s Discharge; Insuficiencia Cardíaca; Educación; Ensayo Clínico; Enfermería; Enfermería de Urgencia; Alta del Paciente; Insuficiência Cardíaca; Educação; Ensaio Clínico; Enfermagem; Enfermagem em Emergência; Alta do Paciente

Objective to evaluate the effectiveness of the behavioral intervention of discharge guidance and telephone follow-up in the therapeutic adherence, re-hospitalization and mortality of patients with heart failure. Method randomized clinical trial without blinding, including 201 patients diagnosed with heart failure admitted to the emergency room, who were randomized in Control Group and Intervention Group. Intervention was carried out with specific discharge guidance in the Intervention Group, who were contacted for solving doubts via phone calls after 7 and 30 days, and the adherence to treatment was evaluated after 90 days with the Morisky test, the Brief Medical Questionnaire and the non-drug adherence test in both groups. The Generalized Estimating Equations Model was used (p<0.05%). Results One-hundred and one patients were randomly sorted in the Control Group and in the Intervention Group, their average age being 62.6±15.2. The Intervention Group had higher drug and non-drug therapeutic adherence compared to the Control Group (p<0.001) and there were lower re-hospitalization and death rates in the Intervention Group after 90 days. Conclusion discharge guidance with telephone follow-up was effective and resulted in greater therapeutic adherence, as well as in decrease of re-hospitalization and death rates in patients with heart failure. Clinical Trial Registration (REBEC): RBR- 37n859